ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,198.10
-0.58%
S&P ASX All Technology
3,744.30
-0.79%
Brent Oil
70.825
-0.81%
US Dollar vs AUD
1.61147
0.16%
Bitcoin
83,276.71
-3.27%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CytoMed Therapeutics Ltd (GDTC) Share Price

CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd (GDTC)

NASDAQ
2.81
0.01
(0.36%)
Closed 04 March 8:00AM
Delayed by 15 minutes
2.81
0.00
(0.00%)
After Hours: 10:06AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.81
Bid
2.51
Offer
2.85
Volume
3,886
2.60 Day's Range 2.81
1.20 52 Week Range 3.98
Market Cap
32.427M
Previous Close
2.80
Open
2.80
Last Trade
178
@
2.81
Last Trade Time
Financial Volume
US$ 10,621
VWAP
2.7331
Average Volume (3m)
229,294
Shares Outstanding
11,540,000
Dividend Yield
-
PE Ratio
-7.85
Earnings Per Share (EPS)
-0.36
Revenue
518k
Net Profit
-4.13M

About CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cytomed.sg.
Headquarters
Singapore, Sgp
Founded
-
CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was US$2.80. Over the last year, CytoMed Therapeutics shares have traded in a share price range of US$ 1.20 to US$ 3.98.

CytoMed Therapeutics currently has 11,540,000 shares in issue. The market capitalisation of CytoMed Therapeutics is US$32.31 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -7.85.

Ask ADVFN Intelligence (AI)

GDTC Latest News

More News

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
07 January 2025
GDTC (0.36%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
06 January 2025
GDTC (0.36%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
06 December 2024
GDTC (0.36%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
20 November 2024
GDTC (0.36%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
05 November 2024
GDTC (0.36%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
07 October 2024
GDTC (0.36%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.093.308823529412.722.812.6116582.75088524CS
40.311.95219123512.512.942.35163112.76397075CS
12-0.14-4.745762711862.953.982.122292943.32816417CS
261.2175.6251.63.981.21104243.26446045CS
520.5423.78854625552.273.981.2722803.00024856CS
156-1.19-29.7549.251.21153314.27473999CS
260-1.19-29.7549.251.21153314.27473999CS

GDTC - Frequently Asked Questions (FAQ)

What is the current CytoMed Therapeutics share price?
The current share price of CytoMed Therapeutics is US$ 2.81
How many CytoMed Therapeutics shares are in issue?
CytoMed Therapeutics has 11,540,000 shares in issue
What is the market cap of CytoMed Therapeutics?
The market capitalisation of CytoMed Therapeutics is USD 32.31M
What is the 1 year trading range for CytoMed Therapeutics share price?
CytoMed Therapeutics has traded in the range of US$ 1.20 to US$ 3.98 during the past year
What is the PE ratio of CytoMed Therapeutics?
The price to earnings ratio of CytoMed Therapeutics is -7.85
What is the cash to sales ratio of CytoMed Therapeutics?
The cash to sales ratio of CytoMed Therapeutics is 62.58
What is the reporting currency for CytoMed Therapeutics?
CytoMed Therapeutics reports financial results in SGD
What is the latest annual turnover for CytoMed Therapeutics?
The latest annual turnover of CytoMed Therapeutics is SGD 518k
What is the latest annual profit for CytoMed Therapeutics?
The latest annual profit of CytoMed Therapeutics is SGD -4.13M
What is the registered address of CytoMed Therapeutics?
The registered address for CytoMed Therapeutics is #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, SINGAPORE, 149544
What is the CytoMed Therapeutics website address?
The website address for CytoMed Therapeutics is www.cytomed.sg.
Which industry sector does CytoMed Therapeutics operate in?
CytoMed Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ACONAclarion Inc
US$ 7.511
(124.21%)
89.21M
BTOGBit Origin Ltd
US$ 0.3209
(76.32%)
291.2M
BTAIBioXcel Therapeutics Inc
US$ 3.73
(72.69%)
146.85M
CLROClearOne Inc
US$ 0.78
(50.87%)
33.41M
ATLNAtlantic International Corporation
US$ 3.1674
(50.11%)
615.54k
BLNEEastside Distilling Inc
US$ 0.7237
(-90.57%)
53.57k
NVNINVNI Group Ltd
US$ 0.3798
(-62.40%)
38.31M
AGMHAGM Group Holdings Inc
US$ 0.1304
(-60.32%)
9.47M
PLRXPliant Therapeutics Inc
US$ 1.38
(-59.88%)
19.51M
AGHAureus Greenway Holdings Inc
US$ 2.23
(-59.01%)
3.8M
NVDANVIDIA Corporation
US$ 114.06
(-8.69%)
411.52M
BTOGBit Origin Ltd
US$ 0.3209
(76.32%)
292.77M
FTFTFuture FinTech Group Inc
US$ 0.249
(23.27%)
219.93M
SPGCSacks Parente Golf Inc
US$ 0.187
(-10.35%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12.6667
(-5.82%)
154.66M

GDTC Discussion

View Posts
glenn1919 glenn1919 3 months ago
GDTX..................................https://stockcharts.com/h-sc/ui?s=GDTX&p=W&b=5&g=0&id=p86431144783



.................thx...............................
👍️0
tw0122 tw0122 3 months ago
Above $3 at $3.04 + 32% for this low float cancer play 
👍️0
Monksdream Monksdream 7 months ago
GDTC under $3
👍️0
glenn1919 glenn1919 8 months ago
GDTC.............https://stockcharts.com/h-sc/ui?s=GDTC&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
GDTC under $3
👍️0
Awl416 Awl416 1 year ago
Halt
👍️0
Monksdream Monksdream 2 years ago
GDTC gap fill candidate bears gotta love it
👍️0
Eurotradr Eurotradr 2 years ago
So much further to go. $10 min.
👍️0
Monksdream Monksdream 2 years ago
GDTC No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
AJ Freely AJ Freely 2 years ago
$GDTC -Up 300% from yesterdays close
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
Current Price $9.63
👍️0
Monksdream Monksdream 2 years ago
Nurse Sherry bought 100 at $7.50
👍️0

Your Recent History

NASDAQ
GDTC
CytoMed Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads